Jindřich Činátl

Active 1996–2025

Also published as
Jindrich Cinatl · Jindrich Cínatl
123
Papers
20,276
Citations
74
h-index
116
i10-index

Citations

Citations per year for Jindřich Činátl1991: 1 citations1992: 1 citations1995: 1 citations1998: 2 citations1999: 3 citations2002: 11 citations2003: 81 citations2004: 232 citations2005: 189 citations2006: 128 citations2007: 112 citations2008: 96 citations2009: 99 citations2010: 123 citations2011: 119 citations2012: 123 citations2013: 132 citations2014: 137 citations2015: 104 citations2016: 85 citations2017: 97 citations2018: 92 citations2019: 267 citations2020: 1,941 citations2021: 1,558 citations2022: 937 citations2023: 506 citations2024: 536 citations2025: 230 citations2026: 6 citations1993–1994: no citations, so these years are not shown1996–1997: no citations, so these years are not shown2000–2001: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,278 citing papers, 19.9% of this breakdownChina: 1,564 citing papers, 13.7% of this breakdownGermany: 727 citing papers, 6.4% of this breakdownUnited Kingdom: 574 citing papers, 5% of this breakdownIndia: 541 citing papers, 4.7% of this breakdownItaly: 408 citing papers, 3.6% of this breakdownCanada: 296 citing papers, 2.6% of this breakdownFrance: 294 citing papers, 2.6% of this breakdownNetherlands: 238 citing papers, 2.1% of this breakdownAustralia: 232 citing papers, 2% of this breakdownSpain: 227 citing papers, 2% of this breakdownJapan: 226 citing papers, 2% of this breakdown
0%19.9%Other 33.4%

Fields

  • Medicine61.3%
  • Biochemistry, Genetics and Molecular Biology15.5%
  • Computer Science4.8%
  • Immunology and Microbiology4.7%
  • Pharmacology, Toxicology and Pharmaceutics3%
  • Agricultural and Biological Sciences2.5%
  • Other8.2%

Topics

  • SARS-CoV-2 and COVID-19 Research13%
  • COVID-19 Clinical Research Studies8%
  • Computational Drug Discovery Methods3%
  • Animal Virus Infections Studies2.8%
  • Viral gastroenteritis research and epidemiology2.7%
  • Long-Term Effects of COVID-192.6%
  • Other67.9%

Coauthors

All papers

Open in search
  1. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature 2020 cited by 1,247

  2. Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2003 cited by 4,774

  3. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

    Authors: , , , , , , , - Nature 2020 cited by 1,115

  4. The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roberto Villaseñor, Olaf Jöhren, Hermann C. Altmeppen, Manolis Pasparakis, Stefanie Dimmeler, Jindřich Činátl, Klaus Püschel, Matija Zelic, Dimitry Ofengeim, Christine Stadelmann, François Trottein, Rubén Nogueiras, Rolf Hilgenfeld, Markus Glatzel, Vincent Prévot, Markus Schwaninger - Nature Neuroscience 2021 cited by 263

  5. Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells

    Authors: , , , , , , , , , , , , , , , , - PLoS ONE 2008 cited by 751

  6. Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2021 cited by 114

  7. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cardiovascular Research 2020 cited by 269

  8. Artesunate Impairs Growth in Cisplatin-Resistant Bladder Cancer Cells by Cell Cycle Arrest, Apoptosis and Autophagy Induction

    Authors: , , , , , , , , , - Cells 2020 cited by 112

  9. Primary Cilia Mediate Diverse Kinase Inhibitor Resistance Mechanisms in Cancer

    Authors: , , , , , , , , , , , , - Cell Reports 2018 cited by 118

  10. CETSA interaction proteomics define specific RNA-modification pathways as key components of fluorouracil-based cancer drug cytotoxicity

    Authors: , , , , , , , , , , , , - Cell chemical biology 2021 cited by 49

  11. Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies

    Authors: , , , - Virology 2007 cited by 172

  12. Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates

    Authors: , , , , , - Cell Research 2022 cited by 120

  13. Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virus-infected cells

    Authors: , , , - Antiviral Research 2012 cited by 190

  14. SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2016 cited by 185

  15. Plant-Derived Sulforaphane Suppresses Growth and Proliferation of Drug-Sensitive and Drug-Resistant Bladder Cancer Cell Lines In Vitro

    Authors: , , , , , , , , , , - Cancers 2022 cited by 30

  16. Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells

    Authors: , , , , , , , , , , , , , , , , - Cell Death and Disease 2011 cited by 198

  17. Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells

    Authors: , , , , , , , , , , , , , , , - Frontiers in Oncology 2022 cited by 30

  18. Metallodrug Profiling against SARS‐CoV‐2 Target Proteins Identifies Highly Potent Inhibitors of the S/ACE2 interaction and the Papain‐like Protease PLpro

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Catherine Hemmert, Heinz Gornitzka, Е. Р. Милаева, Alexey A. Nazarov, Gilles Gasser, John Spencer, Luca Ronconi, Ulrich Kortz, Jindřich Činátl, Denisa Bojková, Ingo Ott - Chemistry - A European Journal 2021 cited by 75

  19. Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants

    Authors: , , , , , , , , , , , , , , , , , - Basic Research in Cardiology 2021 cited by 56

  20. Drug Sensitivity of Currently Circulating Mpox Viruses

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2022 cited by 34

  21. Antiviral Activity of Glycyrrhizic Acid Derivatives against SARS−Coronavirus

    Authors: , , , , , , , - Journal of Medicinal Chemistry 2005 cited by 418

  22. The Story of Human Cytomegalovirus and Cancer: Increasing Evidence and Open Questions

    Authors: , , - Neoplasia 2009 cited by 297

  23. TheAcinetobactertrimeric autotransporter adhesin Ata controls key virulence traits ofAcinetobacter baumannii

    Authors: , , , , , , , , , , , , , , , , - Virulence 2019 cited by 78

  24. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest

    Authors: , , , , , , , , , , - PLoS ONE 2017 cited by 172